Companies: 10,795·Total market cap: $144.5T
Becton, Dickinson and Company

Becton, Dickinson and Company

BDXNYSEHealthcare● Active
$150.74
$-0.43(-0.28%)
Market Cap$54.6B
P/E Ratio
52W High$187.35
52W Low$127.58648

Becton, Dickinson and Company (BDX) Insider Trading

Form 4 buy vs sell counts, ratio, and sentiment — switch this quarter or last 12 months; chart and transactions below.

SEC EDGAR · FMP · BDX · as of Jun 8, 2026

Activity summary

Buy transactions

1

P-Purchase only

Sell transactions

20

12 Months

Buy/Sell ratio

0.05

Buy/Sell (by trades)

Overall sentiment

BEARISH
↑ Buy 5%Active transactions only · RSU vesting excluded95% Sell ↓

Becton, Dickinson and Company insiders have been primarily selling shares over the past 12 Months. Selling activity is often driven by pre-scheduled Rule 10b5-1 plans rather than negative sentiment toward the company.

Source: SEC EDGAR · Form 3 & 4 · via Financial Modeling Prep · Buy = P-Purchase only · Sell = S-Sale only

As of Jun 8, 2026

BDX insider buying and selling by quarter

BDX insider selling · BDX insider buying stocks · quarterly insider activity

Total insider buying (incl. awards)Total insider selling
255K127K0
2025 Q3
2025 Q4
2026 Q1
2026 Q2

Mobile shows last 4Q · Desktop shows full 8Q

Source: SEC EDGAR · Form 3 & 4 · via Financial Modeling Prep · last 8 quarters

As of Jun 8, 2026

Active insiders

Most active in past 12 months · BDX ceo insider trading

Showing all insiders · Click a card to filter the transactions table below

Aggregated from reportingName · top 5 by trade count (12M) · no extra API

Recent insider transactions

BDX executive sell shares · BDX board member insider trading · BDX insider trading SEC filing

Showing 72 most recent · Common Stock · Form 4 only

Scroll horizontally to see all columns

Polen Thomas E Jr

Chairman, CEO and President · Director

Option

Date

Jun 1

Shares

20,209

Price

$126.16

Value

$2.55M ⚡

View Form 4 on SEC.gov

Polen Thomas E Jr

Chairman, CEO and President · Director

Sale

Date

Jun 1

Shares

2,764

Price

$146.35

Value

$405K

View Form 4 on SEC.gov

Polen Thomas E Jr

Chairman, CEO and President · Director

Other

Date

Jun 1

Shares

17,445

Price

$146.15

Value

$2.55M ⚡

View Form 4 on SEC.gov

Menziuso Peter

EVP and President, BDI

Award

Date

Jun 1

Shares

14,258

Price

Value

View Form 4 on SEC.gov

Feld Michael

EVP, Chief Revenue Officer

Sale

Date

May 26

Shares

75

Price

$147.35

Value

$11K

View Form 4 on SEC.gov

Roque Vitor

EVP & Chief Financial Officer

Award

Date

May 7

Shares

1,721

Price

Value

View Form 4 on SEC.gov

Feld Michael

EVP, Chief Revenue Officer

Sale

Date

Apr 27

Shares

74

Price

$151.94

Value

$11K

View Form 4 on SEC.gov

Neal Shana Carol

EVP and Chief People Officer

Other

Date

Apr 6

Shares

1,146

Price

Value

View Form 4 on SEC.gov

Feld Michael

EVP, Chief Revenue Officer

Sale

Date

Mar 26

Shares

75

Price

$156.83

Value

$12K

View Form 4 on SEC.gov

Minnix Lanesha

EVP and General Counsel

Award

Date

Mar 16

Shares

7,492

Price

Value

View Form 4 on SEC.gov

Roque Vitor

Interim CFO

Award

Date

Mar 2

Shares

931

Price

Value

View Form 4 on SEC.gov

Spikner Pamela L.

SVP Controller & CAO

Award

Date

Mar 2

Shares

931

Price

Value

View Form 4 on SEC.gov

Feld Michael

EVP, Chief Revenue Officer

Sale

Date

Feb 26

Shares

75

Price

$181.84

Value

$14K

View Form 4 on SEC.gov

SCOTT BERTRAM L

Director

Sale

Date

Feb 18

Shares

953

Price

$182.61

Value

$174K

View Form 4 on SEC.gov

Henderson Jeffrey William

Director

Award

Date

Jan 27

Shares

1,098

Price

Value

View Form 4 on SEC.gov

ECKERT R ANDREW

Director

Award

Date

Jan 27

Shares

1,098

Price

Value

View Form 4 on SEC.gov

Byington Carrie L

Director

Award

Date

Jan 27

Shares

1,098

Price

Value

View Form 4 on SEC.gov

HAYES GREGORY

Director

Award

Date

Jan 27

Shares

1,098

Price

Value

View Form 4 on SEC.gov

Brown William M

Director

Award

Date

Jan 27

Shares

1,098

Price

Value

View Form 4 on SEC.gov

Huffines Robert Luther

Director

Award

Date

Jan 27

Shares

1,098

Price

Value

View Form 4 on SEC.gov

Jones Christopher Ian Montague

Director

Award

Date

Jan 27

Shares

1,098

Price

Value

View Form 4 on SEC.gov

RING TIMOTHY M

Director

Award

Date

Jan 27

Shares

1,098

Price

Value

View Form 4 on SEC.gov

SCOTT BERTRAM L

Director

Award

Date

Jan 27

Shares

1,098

Price

Value

View Form 4 on SEC.gov

Waldstreicher Joanne

Director

Award

Date

Jan 27

Shares

1,098

Price

Value

View Form 4 on SEC.gov

Wright Jacqueline

Director

Award

Date

Jan 27

Shares

1,098

Price

Value

View Form 4 on SEC.gov

⚡ = value ≥ $1M · Award/Option price shows — · formType=4 · securityName=Common Stock · url → sec.gov/Archives/edgar

1 / 3

Source: SEC EDGAR · Form 4 filings · ⚡ = value ≥ $1M · Award/Option price shows —

About BDX insider trading

BDX insider trades

Becton, Dickinson and Company (BDX) insider trading data is sourced from SEC Form 4 filings submitted by corporate insiders, including Feld Michael (EVP, Chief Revenue Officer), Garrison Michael David (EVP & Pres Med.Essntl&BioPharm), Polen Thomas E Jr (Chairman, CEO and President · Director). Over the past 12 months, 5 insiders have filed transactions with the SEC. BDX insiders have been primarily selling, which may reflect pre-scheduled Rule 10b5-1 plan executions.

For Becton, Dickinson and Company's institutional ownership breakdown and insider ownership percentage, see the Ownership tab → Ownership tab →

Buy/Sell signal logic
acquisitionOrDisposition field:
A = Acquisition (buy) · D = Disposition (sell)
RSU vesting (M-Exempt) excluded from sentiment
Form 4SEC filing required within 2 business days of any insider transaction
10b5-1Pre-scheduled trading plan that allows insiders to sell on autopilot
Open MktDirect purchase or sale on the open market (excludes awards, options)

Frequently asked questions

BDX insider trading · 5 questions

The insiders of Becton, Dickinson and Company (BDX) include executives and directors such as Feld Michael (EVP, Chief Revenue Officer), Garrison Michael David (EVP & Pres Med.Essntl&BioPharm), Polen Thomas E Jr (Chairman, CEO and President · Director), among others. Over the past 12 months, 5 insiders have filed Form 4 transactions with the SEC. Insider transactions are required to be reported within 2 business days of the trade date.

BDX board member insider tradingwho are BDX insidersBDX insider rosterBecton, Dickinson and Company executives insider activity

Source: FMP /stable/insider-trading/search · SEC EDGAR Form 3 & 4 · acquisitionOrDisposition A=Buy, D=Sell · RSU vesting (M-Exempt) excluded from sentiment bar · As of Jun 8, 2026